|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007115,
umls-concept:C0032005,
umls-concept:C0040165,
umls-concept:C0040300,
umls-concept:C0046882,
umls-concept:C0146607,
umls-concept:C0205100,
umls-concept:C0332293,
umls-concept:C0441889,
umls-concept:C1280500,
umls-concept:C1516213,
umls-concept:C2348042
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1991-11-26
|
|
pubmed:abstractText |
To investigate whether the addition of 3,5,3'-triiodothyroacetic acid (TRIAC) to thyroxine (T4) treatment can suppress TSH secretion without inducing thyrotoxicosis at the periphery.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
123-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1934526-Depression, Chemical,
pubmed-meshheading:1934526-Dose-Response Relationship, Drug,
pubmed-meshheading:1934526-Drug Administration Schedule,
pubmed-meshheading:1934526-Drug Synergism,
pubmed-meshheading:1934526-Female,
pubmed-meshheading:1934526-Humans,
pubmed-meshheading:1934526-Male,
pubmed-meshheading:1934526-Pituitary Gland,
pubmed-meshheading:1934526-Thyroid Gland,
pubmed-meshheading:1934526-Thyroid Neoplasms,
pubmed-meshheading:1934526-Thyrotropin,
pubmed-meshheading:1934526-Thyroxine,
pubmed-meshheading:1934526-Triiodothyronine
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
|
|
pubmed:affiliation |
Institute Gustave-Roussy, Villejuif, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
